Despite the overwhelming evidence pointing to certain Aβ peptides and hyper-phosphorylated tau being the misfolded and toxic species underlying AD, clinical trials aimed at reducing the Aβ load have been largely unsuccessful. Here, MAPT is linked to Alzheimer disease.